Carlier SPRL

3 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• UNSAFE COL2 refused lines

  Color additive unsafe under section 721

  The product appeared to be, or to contain, a color additive that is unsafe within the meaning of section 721(a) of the FD&C Act, the section that governs which color additives may be used and how.

• LACKS N/C1 refused line

  Net quantity statement missing

  The packaged food appeared not to carry an accurate statement of the quantity of contents, such as net weight, measure, or count, on its label.

• LIST INGRE1 refused line

  Ingredients not listed

  The product is made from two or more ingredients and the label appeared not to list the common or usual name of each one (or, for a juice beverage, the percentage of juice).

Questions about Carlier SPRL

Is Carlier SPRL on an FDA import alert?

Yes. As of October 25, 2026, Carlier SPRL is on the red list of FDA Import Alert 45-02, “Foods with illegal or undeclared colors”, for luxe bar (soft nougat bar) pistachio; FDA published the listing on December 2, 2016.

Has FDA refused shipments from Carlier SPRL?

Yes. FDA refused 2 shipment lines from Carlier SPRL between January 24, 2017 and March 6, 2026. The most recent, on March 6, 2026, was mixed/assorted soft candy with nuts and fruit (without chocolate), charged as UNSAFE COL (color additive unsafe under section 721).

Why did FDA refuse Carlier SPRL's shipments?

The most frequent charges are UNSAFE COL (color additive unsafe under section 721, 2 lines) and LACKS N/C (net quantity statement missing, 1 line).

What is Carlier SPRL's FEI number?

Carlier SPRL's FDA Establishment Identifier (FEI) is 3013239227.

Can shipments from Carlier SPRL still enter the U.S.?

Shipments of luxe bar (soft nougat bar) pistachio from Carlier SPRL can be detained without physical examination under Import Alert 45-02; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).